TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...

TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...

A recent study described develops methods for synthesizing and quantifying metal-induced glycation products, particularly in ...

Despite hosting more oncology start-ups, Europe is lagging in the development of cancer technologies, losing the competitive ...

AliveDx’s CE mark for the systematic autoimmune rheumatic disease (SARD) assay marks its fifth approval in the past 18 months ...

Advance quantum information systems through innovative material design. Develop ultrasensitive biosensors for non-invasive ...

Intelligent Bio Solutions Inc. (NASDAQ:INBS – Get Free Report) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 427,400 ...

There are notable differences between men and women in their susceptibility to many human diseases, including cardiovascular ...

Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has been given an average rating of “Moderate Buy” by the five ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).